Trials / Completed
CompletedNCT00222898
Cancer Detection in Pancreatic Cysts
Pancreatic Cyst DNA Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (planned)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assist with early and accurate diagnosis of cancer in pancreatic cysts based on the analysis of DNA obtained by endoscopic ultrasound guided fine needle aspiration
Detailed description
The study of pancreatic diseases is hindered by the organ's deep seated location and especially lack of symptoms during the early stages of disease development and progression e.g. pancreatic cancer. This is particularly true of pancreatic cysts, the variety and the malignant potential of which encompass a broad spectrum. The radiological features distinguishing a benign from a pre-malignant to a frankly malignant cyst in the pancreas are frequently underwhelming and have lead to the clinical practice of sampling all but the most obvious. The yield of the aspirate in turn is frequently not of a quality upon which a clinical decision can be based. Most would agree that the best approach for management of pancreatic cystic neoplasm lies in early diagnosis, ideally at a precancerous stage. The effectiveness and applicability of this study is the based on the ability of the cyst DNA analysis to stratify the patients at risk of developing pancreatic cancer based on the extent of accumulated mutational damage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | DNA analysis of pancreatic cyst fluid / buccal swab |
Timeline
- Start date
- 2004-06-01
- First posted
- 2005-09-22
- Last updated
- 2007-02-19
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00222898. Inclusion in this directory is not an endorsement.